Bacterial Proctitis Treatment Guidelines
Introduction to Bacterial Proctitis
- Bacterial proctitis is a condition that requires prompt diagnosis and treatment to prevent complications, with the Centers for Disease Control and Prevention (CDC) and the Infectious Diseases Society of America (IDSA) providing guidelines for management 1, 2, 3
Diagnosis and Testing
- Patients with suspected proctitis should undergo anoscopic examination, Gram-stained smear of anorectal exudate, and testing for HSV, N. gonorrhoeae, C. trachomatis, T. pallidum, HIV, and syphilis, as recommended by the CDC 2
- Comprehensive testing is essential to identify multiple pathogens that may be present simultaneously, with the CDC emphasizing the importance of thorough diagnostic testing 2
- All patients with acute proctitis should be tested for HIV and syphilis, according to the CDC guidelines 2
Treatment Regimens
- The IDSA recommends a 7-day regimen of fluoroquinolones, including levofloxacin, for most bacterial infections with prompt resolution of symptoms 3
- A 5-day regimen of levofloxacin may be considered in patients who are not severely ill and show rapid clinical improvement, according to the IDSA guidelines 3
- The CDC recommends an empiric treatment regimen of ceftriaxone 125 mg IM as a single dose PLUS doxycycline 100 mg orally twice daily for 7 days for suspected infectious proctitis, effective against anal and genital gonorrhea, while awaiting test results 1, 2
- For Neisseria gonorrhoeae, ceftriaxone is the preferred treatment due to increasing antimicrobial resistance, with alternative regimens including gentamicin 240 mg IM single dose plus azithromycin 2 g orally single dose for cephalosporin allergy 4
- For Chlamydia trachomatis, the standard treatment is doxycycline 100 mg twice daily for 7 days, with alternative regimens including azithromycin 1.0-1.5 g orally as a single dose, and extended doxycycline for 3 weeks total for LGV serovars 4
- For Herpes simplex virus, specific antiviral therapy is required, and may be especially severe in HIV-coinfected patients, with high-quality evidence supporting this association 1, 5, 2
Treatment Duration and Extension
- Delayed clinical response may warrant extending treatment to 10-14 days, as suggested by the IDSA 3
- Patients with bloody discharge, perianal ulcers, mucosal ulcers, positive rectal chlamydia NAAT, or HIV infection should have their doxycycline treatment extended to 3 weeks total for presumptive lymphogranuloma venereum (LGV) treatment 1, 2
Alternative and Adjunctive Therapies
- The American College of Gastroenterology recommends 1 g mesalamine (5-ASA) suppository once daily as the first-line treatment for proctitis, with the option to reduce frequency or switch to oral 5-ASA to improve adherence 6
- The European Crohn’s and Colitis Organisation recommends combining topical mesalamine with oral mesalamine or topical steroids for proctitis, as it is more effective than monotherapy 7
- Suppositories are preferred for proctitis as they deliver medication more effectively to the rectum and are better tolerated than enemas, according to the European Crohn’s and Colitis Organisation 7
Prevention of Reinfection and Transmission
- Patients should abstain from sexual intercourse until they and their partner(s) have completed treatment and symptoms have resolved, as recommended by the CDC 2
- Sexual partners from the past 60 days should be evaluated, tested, and treated presumptively, and both patient and partners should abstain from sexual intercourse until treatment completion and symptom resolution, as recommended by the CDC 2
- For proctitis associated with gonorrhea or chlamydia, retesting should be performed 3 months after treatment, as recommended by the CDC 2
Special Considerations
- Reinfection may be difficult to distinguish from treatment failure, with multiple references supporting this challenge 5, 1, 2
- Not considering proximal constipation, which can affect drug delivery in distal colitis and should be addressed with laxatives if present, as noted by 7
- Missing refractory disease, for which IV steroid therapy, alternative topical therapies, or surgical options may be considered if disease persists, based on expert opinion 7
- Failing to distinguish between infectious and inflammatory causes of proctitis, not considering co-existing irritable bowel syndrome, and missing other conditions that may cause symptoms, as highlighted by 6